Jr GR, Canton ED, Vega ML, Greco M, Sr GR, Valsecchi ME. Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions. World J Clin Oncol 2014; 5(3): 440-454 [PMID: 25114858 DOI: 10.5306/wjco.v5.i3.440]
Corresponding Author of This Article
Matias E Valsecchi, MD, MS, Medical Oncology, HIMG, 5170 US Route 60 East, Huntington, WV 25705, United States. meval78@yahoo.com
Research Domain of This Article
Oncology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/